Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Ukraine
World Economic Forum (WEF)
Davos
COVID-19
China
Quadrilateral Security Dialogue
Omicron variant
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / World News / US planning Pfizer's coronavirus vaccine distribution as early as December
World

US planning Pfizer's coronavirus vaccine distribution as early as December

US planning Pfizer's coronavirus vaccine distribution as early as December
Written by Shalini Ojha
Nov 12, 2020, 12:35 am 3 min read
US planning Pfizer's coronavirus vaccine distribution as early as December

The United States could begin inoculating its citizens with Pfizer's coronavirus vaccine as early as December, provided the drugmaker submits data from its trial to health regulators, Health Secretary Alex Azar said on Tuesday. On Monday, the US-based company announced that its vaccine was found to be 90% effective in large-scale late-stage trials. German biotech firm BioNTech is also developing the vaccine.

Plan
The availability depends on FDA's approval

If things go well, Pfizer could have the safety data by next week, which would be sent to the US Food and Drug Administration for emergency use authorization. Once FDA approves, the country will receive nearly 20 million doses of the vaccine per month. As per Azar, the United States Department of Health and Human Services would begin procuring supplies by end of November.

Details
Healthcare workers, high-risk individuals will get vaccinated first

While speaking to CNBC, Azar said the vaccine's efficiency will decide the next steps. He revealed the elderly in nursing homes, healthcare workers, and first responders, will be the first ones to be inoculated. He hoped this process would wrap up by January-end. Azar is confident other vaccines, like the one being developed by Moderna Inc., will also become available soon.

Statement
Dr. Fauci eager to take Pfizer vaccine

Separately, the worst-hit nation's infectious disease expert Dr. Anthony Fauci also expressed confidence in Pfizer, going as far as saying that he would also take the vaccine once the FDA approves it. "I'm going to look at the data, but I trust Pfizer. I trust the FDA. These are colleagues of mine for decades, the career scientists," Dr. Fauci told MSNBC.

Quote
He would also recommend the vaccine to his family

"If they look at this data, and they say this data is solid, let's go ahead and approve it, I promise you, I will take the vaccine, and I will recommend that my family take the vaccine," Dr. Fauci added.

Talks
Meanwhile, Pfizer is also in talks with the Indian government

The US drugmaker is also in talks with the Indian government to sell its vaccine, a spokesperson said. "We remain committed to advance our dialogue with the Government of India to make this vaccine available for use in the country," a Pfizer India spokesperson revealed, adding that the company could produce nearly 50 million doses in 2020, and about 1.3 billion doses in 2021.

Problems
However, the vaccine comes with its own set of riders

It is worth highlighting that Pfizer has not signed any pact with India or World Health Organization, which is leading the vaccine initiative called Covax. What makes the distribution of Pfizer's vaccine more cumbersome is the fact that it has to be stored at a temperature of -75°C ±15°C. India doesn't have the required infrastructure, hence, didn't show enthusiasm in signing a deal.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Shalini Ojha
Shalini Ojha
Twitter
A mathematics graduate, I handle the national desk. Always looking for items to read, I started off as an entertainment beat writer and made the switch three years into my career. My talents include breaking news and being on top of trending topics.
Latest
CNBC
Pfizer
MSNBC
United States of America
Coronavirus
Related
Latest
Realme GT Neo 3 now has a 512GB storage variant
Realme GT Neo 3 now has a 512GB storage variant Technology
IPL 2022: Rajasthan Royals beat RCB to reach final
IPL 2022: Rajasthan Royals beat RCB to reach final Sports
2022 French Open: Leylah Fernandez progresses; Victoria Azarenka ousted
2022 French Open: Leylah Fernandez progresses; Victoria Azarenka ousted Sports
2022 French Open: Vintage Rafael Nadal marches on
2022 French Open: Vintage Rafael Nadal marches on Sports
No international link in Cordelia drugs case: NCB DG
No international link in Cordelia drugs case: NCB DG India
CNBC
Reddit's WallStreetBets goes private; banned on Discord for 'hate speech'
Reddit's WallStreetBets goes private; banned on Discord for 'hate speech' Business
Bengaluru: Disgruntled workers wreak havoc at Wistron's iPhone manufacturing plant
Bengaluru: Disgruntled workers wreak havoc at Wistron's iPhone manufacturing plant India
Meet the Bidens in India: US President-elect's 'distant relatives'
Meet the Bidens in India: US President-elect's 'distant relatives' World
Global markets fall after US President Trump reveals coronavirus diagnosis
Global markets fall after US President Trump reveals coronavirus diagnosis World
End of TikTok's woes? Trump approves Oracle's bid for TikTok
End of TikTok's woes? Trump approves Oracle's bid for TikTok Business
More News
Pfizer
New Omicron sub-variants can trigger new COVID-19 wave: Study
New Omicron sub-variants can trigger new COVID-19 wave: Study World
Pfizer, BioNTech begin clinical trial for Omicron-specific vaccine
Pfizer, BioNTech begin clinical trial for Omicron-specific vaccine World
'Cautious optimism' after initial Omicron studies; here's what we know
'Cautious optimism' after initial Omicron studies; here's what we know Technology
COVID-19 vaccine: Study finds AstraZeneca booster jab safe, effective
COVID-19 vaccine: Study finds AstraZeneca booster jab safe, effective Technology
COVID-19: India reports 10K+ infections; 301 more deaths
COVID-19: India reports 10K+ infections; 301 more deaths India
More News
MSNBC
Tom Hanks, JLo, Gaga to light up Joe Biden's inauguration
Tom Hanks, JLo, Gaga to light up Joe Biden's inauguration Entertainment
HBO viewership dropped massively, thanks to 'GoT' ending, COVID-19
HBO viewership dropped massively, thanks to 'GoT' ending, COVID-19 Entertainment
What sexual-assault charges does White House hopeful Joe Biden face?
What sexual-assault charges does White House hopeful Joe Biden face? World
Why Zuckerberg ordered Facebook executives to not use iPhones
Why Zuckerberg ordered Facebook executives to not use iPhones Technology
Donald Trump tells hurricane survivor to 'have a good time'
Donald Trump tells hurricane survivor to 'have a good time' World
More News
United States of America
A look at deadliest school shootings; Texas leads the way
A look at deadliest school shootings; Texas leads the way World
Monkeypox: Maharashtra, Tamil Nadu, Rajasthan prepare to fight against virus
Monkeypox: Maharashtra, Tamil Nadu, Rajasthan prepare to fight against virus India
PM Modi meets Japanese IT giant head, discusses investment opportunities
PM Modi meets Japanese IT giant head, discusses investment opportunities World
Afghan women TV hosts cover faces after Taliban's diktat
Afghan women TV hosts cover faces after Taliban's diktat World
'Concerned' WHO expects more monkeypox cases globally
'Concerned' WHO expects more monkeypox cases globally World
More News
Coronavirus
COVID-19: India logs 3,303 new cases; 39 more deaths
COVID-19: India logs 3,303 new cases; 39 more deaths India
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man India
COVID-19 vaccine precautionary dose available for 18+ from April 10
COVID-19 vaccine precautionary dose available for 18+ from April 10 India
COVID-19 survivors at risk of developing serious blood clots: Study
COVID-19 survivors at risk of developing serious blood clots: Study Technology
COVID-19: India reports 1,660 new cases, 4,100 more deaths
COVID-19: India reports 1,660 new cases, 4,100 more deaths India
More News
Related
US: Pfizer-BioNTech COVID-19 vaccine officially granted full approval by FDA
US: Pfizer-BioNTech COVID-19 vaccine officially granted full approval by FDA World
Pfizer-BioNTech COVID-19 vaccine to get US-FDA's full approval next week
Pfizer-BioNTech COVID-19 vaccine to get US-FDA's full approval next week World
US will distribute 500M Pfizer vaccine doses to 100 countries
US will distribute 500M Pfizer vaccine doses to 100 countries World
India is among beneficiaries receiving 25 million vaccines from US
India is among beneficiaries receiving 25 million vaccines from US World
Next News Article
Next News Article

Love World news?

Subscribe to stay updated.

World Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022